Company Filing History:
Years Active: 2017
Title: Innovations of Ronald Erwin Boch in Influenza Treatment
Introduction
Ronald Erwin Boch is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of treatments for influenza. His innovative approach combines scientific research with practical applications, showcasing his dedication to improving public health.
Latest Patents
Ronald Erwin Boch holds a patent for "Compositions and methods for treating influenza." This patent presents compositions and methods that are useful for treating influenza. The disclosed compositions include an influenza virus hemagglutinin antigen combined with lipid vesicles that contain a non-ionic surfactant (NISVs) and optionally an adjuvant. Notably, these compositions remain potent even when not stored in a standard cold-chain system, making them thermostable and more accessible for use in various environments.
Career Highlights
Throughout his career, Ronald has been associated with Variation Biotechnologies Inc., where he has focused on developing innovative solutions for viral infections. His work has been instrumental in advancing the understanding and treatment of influenza, contributing to the broader field of infectious disease research.
Collaborations
Ronald has collaborated with esteemed colleagues, including David E. Anderson and Andrei Ogrel. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
In summary, Ronald Erwin Boch's contributions to influenza treatment through his innovative patent demonstrate his commitment to advancing medical science. His work not only addresses a critical health issue but also exemplifies the importance of innovation in biotechnology.